SCHEMBL3989388

SCHEMBL3989388

O=C1CCc2c1ccc(O)c2Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 1/20 0.41
HSD17B1 P14061 4/20 0.40
PBRM1 Q86U86 1/20 0.37
ACHE P22303 1/20 0.37
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
PRKCI P41743 1/20 0.35
PSMB5 P28074 1/20 0.35
STS P08842 1/20 0.34
BCL2 P10415 1/20 0.33
MCL1 Q07820 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
EGFR P00533 1/20 0.33
GAA P10253 2/20 0.32
HTT P42858 1/20 0.32
CSNK2A1 P68400 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31125679 1.00 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B1PBRM1
SCHEMBL3987533 0.89 MAOA (0.44) KDM4EALDH1A1HSD17B1ACHEMAOA
SCHEMBL1535917 0.79 ACHE (0.56) KDM4EALDH1A1HPGDHSD17B1PBRM1
SCHEMBL19950131 0.76 HSD17B1 (0.47) KDM4EALDH1A1HPGDHSD17B1PBRM1
SCHEMBL11663902 0.76 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B1MAOA
SCHEMBL296542 0.76 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B1CASP1
SCHEMBL30070327 0.76 HSD17B1 (0.47) KDM4EALDH1A1HPGDHSD17B1PBRM1
SCHEMBL386061 0.76 SLC22A8 (0.49) KDM4EALDH1A1HPGDHSD17B1PBRM1
SCHEMBL15287071 0.76 CASP1 (0.41) KDM4EALDH1A1HPGDHSD17B1MCL1
SCHEMBL29660467 0.76 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11731961-B2 Phenyl propionic acid derivatives and uses thereof ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-08-22 US disclosed
US-11731961-B2 Phenyl propionic acid derivatives and uses thereof ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-08-22 US disclosed
US-11731961-B2 Phenyl propionic acid derivatives and uses thereof ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-08-22 US disclosed
EP-3555076-B1 NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF IL DONG PHARMA (KR) 2023-04-05 EP disclosed
CN-110049984-B Phenylpropionic acid derivatives and use thereof 日东制药株式会社 2022-11-15 CN disclosed
US-20220112185-A1 NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-04-14 US disclosed
US-20220064154-A1 NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF ILDONG PHARMACEUTICAL CO, LTD. (KR) 2022-03-03 US disclosed
US-11225472-B2 Phenyl propionic acid derivatives and uses thereof IL DONG PHARMACEUTICAL CO., LTD. 2022-01-18 US disclosed
CN-113072551-A Nitrogen-containing biphenyl derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2021-07-06 CN disclosed
US-20200223833-A1 NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF IL DONG PHARMACEUTICAL CO., LTD. (KR) 2020-07-16 US disclosed
US-20130289074-A1 NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-31 US disclosed
US-20130289074-A1 NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-31 US disclosed
US-20130289074-A1 NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-31 US disclosed
WO-2013144098-A1 NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-03 WO disclosed
WO-2013144098-A1 NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-03 WO disclosed
US-7485655-B2 2-Aminothiazole allosteric enhancers of A1 adenosine receptors UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2009-02-03 US disclosed
EP-1583530-A4 2-AMINOTHIAZOLE ALLOSTERIC ENHANCERS OF A1-ADENOSINE RECEPTORS UNIV VIRGINIA (US) 2008-07-23 EP disclosed
EP-1583530-A1 2-AMINOTHIAZOLE ALLOSTERIC ENHANCERS OF A1-ADENOSINE RECEPTORS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2005-10-12 EP disclosed
US-20050027125-A1 2-Aminothiazole allosteric enhancers of a ?1? adenosine receptors NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-02-03 US disclosed
WO-2003061655-A1 2-AMINOTHIAZOLE ALLOSTERIC ENHANCERS OF A1 ADENOSINE RECEPTORS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064154-A1 NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF GPR119, GPR65, GPR55 KDM4E 3484/4885ALDH1A1 872/4885HPGD 2338/4885
US-11225472-B2 Phenyl propionic acid derivatives and uses thereof GPR119, GPR55, GPR65 KDM4E 3561/4885ALDH1A1 755/4885HPGD 1872/4885
US-20050027125-A1 2-Aminothiazole allosteric enhancers of a ?1? adenosine receptors ADORA1, ADORA2A, ADORA2B KDM4E 2302/4885ALDH1A1 512/4885HPGD 2608/4885
US-20220112185-A1 NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF GPR119, GPR55, GPR65 KDM4E 3215/4885ALDH1A1 698/4885HPGD 2362/4885
US-20200223833-A1 NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF GPR119, GLP1R, GPR65 KDM4E 3459/4885ALDH1A1 806/4885HPGD 2097/4885
US-20130289074-A1 NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS GPR119, GPR55, GPR52 KDM4E 3506/4885ALDH1A1 216/4885HPGD 1821/4885
US-11731961-B2 Phenyl propionic acid derivatives and uses thereof GPR119, GPR65, GPR55 KDM4E 3730/4885ALDH1A1 731/4885HPGD 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.